Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Plos One|September 13, 2012
MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1Kyu-Tae Kim, Adam P Carroll, Baratali Mashkani, et al.Blood|October 23, 2004
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survivalKyu-Tae Kim, Kristin Baird, Joon-Young Ahn, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitisMario Skarica, Tianhong Wang, Erin McCadden, et al.Blood|March 11, 2010
Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targetingEric Schafer, Rafael Irizarry, Sandeep Negi, et al.Blood Cancer Discovery|September 30, 2021
A method for overcoming plasma protein inhibition of tyrosine kinase inhibitorsDavid J Young, Bao Nguyen, Li Li, et al.Blood|May 29, 2004
Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibitionPatrick Brown, Soheil Meshinchi, Mark Levis, et al.Blood|February 5, 2008
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse modelLi Li, Obdulio Piloto, Ho Bao Nguyen, et al.Blood|January 15, 2008
Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AMLAnnahita Sallmyr, Jinshui Fan, Kamal Datta, et al.Oncotarget|January 13, 2017
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitorsBao Nguyen, Allen B Williams, David J Young, et al.Oncotarget|September 17, 2016
Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine modelJennifer L Poitras, Diane Heiser, Li Li, et al.Pageof 9